Skip to content

Plasma Metabolomic Profiling of COPD Patients Stratified by Smoking Status: A GC-MS-Based Approach

Aug 2026 · bioRxiv · 0 citations · 51 references
Biology

TL;DR

This study reveals distinct plasma metabolic signatures across COPD subgroups categorized by cigarette smoking history, including smokers, ex-smokers, and non-smokers.

View source

Similar papers

Open access Aug 2026

Serum metabolic characteristics of interstitial lung disease: a potential link between endocrine aging and gut-derived metabolites

Untargeted metabolomics has revealed significant systemic metabolic dysregulation in ILD and the biomarkers and “metabolic-immune-endocrine” interaction patterns identified offer potential leads for early diagnosis and targeted treatment, which require validation in larger cohorts.

Lu Liu, Xin-Yi Wang, Jinling Xiao et al. · 0 citations
Open access Sep 2026

Metabolic differences among patients with alcohol-related liver disease using targeted and untargeted metabolomics techniques

Serum levels of five DEMs (Glu, Pro, Orn, Cit, Cit, and Arg) are closely linked to ALD-related metabolic dysregulation; they serve as potential indicators of ALD progression and provide valuable insights for the clinical staging and targeted intervention of ALD.

Jie-Sen Lu, Li Zhao, Tian-Yi Zhu et al. · 0 citations
Open access Aug 2026

Metabolomic profiling reveals distinct and shared biology in COPD and IPF

Alterations in metabolomic profiles of COPD and IPF suggested shared dysregulation of several lipids, however, some metabolites pointed to disease-specific differences.

Aldric Rosario, N. Prince, S. Madha-Krause et al. · 0 citations
Open access Sep 2026

Metabolomics highlights cardiovascular risk factor links to sphingolipid and one-carbon metabolism in asymptomatic adults

Serine depletion by increased demands of sphingolipid, and possibly transsulfuration pathway, metabolism is associated with elevations in cytotoxic deoxyceramides and reductions in glycine and methionine availability for one-carbon metabolism, a key marker of residual CVD risk.

Mengjiang Huang, D. Tacad, Tong Shen et al. · 0 citations
Open access Aug 2026

Metabolomics reveals lipid and amino acid signatures of disease severity in multiple sclerosis

Findings highlight coordinated dysregulation of amino acid and lipoprotein metabolism as hallmarks of established MS and identify a novel association of the omega-6/omega-3 ratio with inflammatory disease activity.

Rachel E. Rodin, B. Healy, Mariann Polgár-Turcsányi et al. · 0 citations
Open access Aug 2026

Peripheral Mononuclear Cells Metabolomics in Obstructive Sleep Apnea Syndrome (OSAS): An Exploratory Pilot Study of Immunometabolic Signatures

Obstructive Sleep Apnea Syndrome (OSAS) is associated with systemic inflammation and immune dysfunction, yet the specific metabolic alterations within immune cells remain poorly understood. In this exploratory study, we characterized the metabolome of peripheral mononuclear cells (PMNCs) from patients with OSAS and hea...

Nour Balasan, Michela Zorzi, B. Ura et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.